CRP and colorectal carcinoma: About 20% of the CRC patients have elevated serum CRP levels29, and increased CRP and mGPS, combined evaluation of serum CRP and albumin, have been linked with adverse clinical outcome and represent promising additional prognostic indicators in CRC28.